Stent-Supported Angioplasty of Severe Atherosclerotic Renal Artery Stenosis Preserves Renal Function and Improves Blood Pressure Control: Long-term Results from a Prospective Registry of 456 Lesions

Journal of Endovascular Therapy

Volumn 11, Issue 2, 2004, Pages 95-106

  Zeller, Thomas ^a,c   Frank, Ulrich ^a   Müller, Christian ^b   Bürgelin, Karlheinz ^a   Sinn, Lutz ^a   Horn, Barbara ^a   Flügel, Peter Christian ^a   Schwarzwälder, Uwe ^a   Roskamm, Helmut ^a   Neumann, Franz Josef ^a  

^a Department of Angiology ^*  (Germany)

^b UNIVERSITY HOSPITAL BASEL   (Switzerland)

^c UNIVERSITY HEART CENTER FREIBURG BAD KROZINGEN   (Germany)

Author keywords

Atherosclerosis; Balloon angioplasty; Blood pressure; Outcome analysis; Renal artery stenosis; Renal function; Serum creatinine; Stent

Indexed keywords

ANTIHYPERTENSIVE AGENT; CREATININE;

ADULT; AGED; ANGIOPLASTY; ARTICLE; ATHEROSCLEROSIS; BLOOD PRESSURE MONITORING; BLOOD PRESSURE REGULATION; CORONARY ARTERY DISEASE; CREATININE BLOOD LEVEL; DIASTOLIC BLOOD PRESSURE; ECHOGRAPHY; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HEMODYNAMICS; HUMAN; HYPERTENSION; KIDNEY ARTERY STENOSIS; KIDNEY BLOOD FLOW; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MEAN ARTERIAL PRESSURE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SYSTOLIC BLOOD PRESSURE; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; ANGIOPLASTY; ARTERIOSCLEROSIS; BLOOD PRESSURE; CREATININE; FEMALE; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; REGISTRIES; RENAL ARTERY OBSTRUCTION; RISK FACTORS; STENTS; TREATMENT OUTCOME; VASCULAR RESISTANCE;

EID: 11144355572     PISSN: 15266028     EISSN: None     Source Type: Journal    
DOI: 10.1583/03-1062.1     Document Type: Article

References (70)

1. Missouris CG, Buckenham T, Cappuccio FP, et al. Renal artery stenosis: a common and important problem in patients with peripheral vascular disease. Am J Med. 1994;96:10-14.
2. Gross CM, Krämer J, Waigand J, et al. Ostial renal artery stent placement for atherosclerotic renal artery stenosis in patients with coronary artery disease. Cathet Cardiovasc Diagn. 1998; 45:1-8.
3. Jean WJ, al-Bitar I, Zwicke DL, et al. High incidence of renal artery stenosis in patients with coronary artery disease. Cathet Cardiovasc Diagn. 1994;32:8-10.
4. Harding MB, Smith LR, Himmelstein SI, et al. Renal artery stenosis: prevalence and associated risk factors in patients undergoing routine cardiac catheterization. J Am Soc Nephrol. 1992;2:1608-1616.
5. Zoccali C, Mallamaci F, Finocchiaro P. Atherosclerotic renal artery stenosis: epidemiology, cardiovascular outcomes, and clinical prediction rules. J Am Soc Nephrol. 2002;13Suppl 3: S179-183.
6. Preston RA, Epstein M. Ischemic renal disease: an emerging cause of chronic renal failure and end-stage renal disease. J Hypertens. 1997;15:1365-1377.
7. Greco BA, Breyer JA. The natural history of renal artery stenosis: who should be evaluated for suspected ischemic nephropathy? Semin Nephrol. 1996;16:2-11.
8. Hansen KJ, Edwards MS, Craven TE, et al. Prevalence of renovascular disease in the elderly: a population-based study. J Vasc Surg. 2002;36:443-451.
9. Rimmer JM, Gennari FJ. Atherosclerotic renovascular disease and progressive renal failure. Ann Intern Med. 1993;118:712-719.
10. Caps MT, Zierler RE, Polissar NL, et al. Risk of atrophy in kidneys with atherosclerotic renal artery stenosis. Kidney Int. 1998;53:735-742.
11. Tollefson DF, Ernst CB. Natural history of atherosclerotic renal artery stenosis associated with aortic disease. J Vasc Surg. 1991;14:327-331.
12. Schreiber MJ, Pohl MA, Novick AC. The natural history of atherosclerotic and fibrous renal artery disease. Urol Clin North Am. 1984;11:383-392.
13. Zierler RE, Bergelin RO, Davidson RC, et al. A prospective study of disease progression in patients with atherosclerotic renal artery stenosis. Am J Hypertens. 1996;9:1055-1061.
14. Zierler RE, Bergelin RO, Isaacson JA, et al. Natural history of atherosclerotic renal artery stenosis: a prospective study with duplex ultrasonography. J Vasc Surg. 1994;19:250-258.
15. Goncharenko V, Gerlock AJ, Shaff MI, et al. Progression of renal artery fibromuscular dysplasia in 42 patients as seen on angiography. Radiology. 1981;139:45-51.
16. Mailloux LU, Napolitano B, Bellucci AG, et al. Renal vascular disease causing end-stage renal disease, incidence, clinical correlates, and outcomes: a 20-year clinical experience. Am J Kidney Dis. 1994;24:622-629.
17. Pattynama P, Becker GJ, Brown J, et al. Percutaneous angioplasty for atherosclerotic renal artery disease: effect on renal function in azotemic patients. Cardiovasc Intervent Radiol. 1994;17:143-146.
18. Safian RD, Textor SC. Renal-artery stenosis. N Engl J Med. 2001;344:431-442.
19. Textor SC. Pathophysiology of renal failure in renovascular disease. Am J Kidney Dis. 1994;24:642-651.
20. Martin LG, Cork RD, Kaufman SL. Long-term results of angioplasty in 110 patients with renal artery stenosis. J Vasc Interv Radiol. 1992;3:619-626.
21. Bonelli FS, McKusick A, Textor SC, et al. Renal artery angioplasty: technical results and clinical outcome in 320 patients. Mayo Clin Proc. 1995;70:1041-1052.
22. Baert AL, Wilms G, Amery A, et al. Percutaneous transluminal renal angioplasty: initial results and long-term follow-up in 202 patients. Cardiovasc Intervent Radiol. 1990;13:22-28.
23. Martin LG, Casarella WJ, Gaylord GM. Azotemia caused by renal artery stenosis: treatment by percutaneous angioplasty. AJR Am J Roentgenol. 1988;150:839-844.
24. Hoffman O, Carreres T, Sapoval MR, et al. Ostial renal artery stenosis angioplasty: immediate and mid-term angiographic and clinical results. J Vasc Interv Radiol. 1998;9:65-73.
25. Van Jaarsveld BC, Krijnen P, Pieterman H, et al. The effect of balloon angioplasty on hypertension in atherosclerotic renal-artery stenosis. Dutch Renal Artery Stenosis Intervention Cooperative Study Group. N Engl J Med. 2000;342:1007-1014.
26. von Knorring J, Edgren J, Lepäntalo M. Long-term results of percutaneous transluminal angioplasty in renovascular hypertension. Acta Radiol. 1996;37:36-40.
27. Harden PN, Sheppard D, Rodger RS, et al. Percutaneous transluminal renal angioplasty (PTRA) in the treatment of chronic renal failure due to renovascular disease. J Nephrol. 1994;7:186-188.
28. Grüntzig A, Kuhlmann U, Vetter W, et al. Treatment of renovascular hypertension with percutaneous transluminal dilatation of a renal-artery stenosis. Lancet. 1978;1:801-802.
29. Klinge J, Mali WP, Puijlaert CB, et al. Perctaneous transluminal renal angioplasty: initial and long-term results. Radiology. 1989;171:501-506.
30. Sos TA, Pickering TG, Sniderman K, et al. Percutaneous transluminal renal angioplasty in renovascular hypertension due to atheroma or fibromuscular dysplasia. N Engl J Med. 1983;309:274-279.
31. Jensen G, Zachrisson BF, Delin K, et al. Treatment of renovascular hypertension: one year results of renal angioplasty. Kidney Int. 1995;48:1936-1945.
32. Ramsay LE, Waller PC. Blood pressure response to percutaneous transluminal angioplasty for renovascular hypertension: an overview of published series. BMJ. 1990;300:569-572.
33. O'Donovan RM, Gutierrez OH, Izzo JL. Preservation of renal function by percutaneous renal angioplasty in high-risk elderly patients: short-term outcome. Nephron. 1992;60:187-192.
34. Pattison JM, Reidy JF, Rafferty MJ, et al. Percutaneous transluminal renal angioplasty in patients with renal failure. Q J Med. 1992;85:883-888.
35. Blum U, Krumme B, Flügel P, et al. Treatment of ostial renal-artery stenoses with vascular endoprostheses after unsuccessful balloon angioplasty. N Engl J Med. 1997;336:459-465.
36. Taylor A, Sheppard D, MacLeod MJ, et al. Renal artery stent placement in renal artery stenosis: technical and early clinical results. Clin Radiol. 1997;52:451-457.
37. Henry M, Amor M, Henry I, et al. Stent placement in the renal artery: three-year experience with the Palmaz stent. J Vasc Interv Radiol. 1996;7:343-350.
38. Harden PN, MacLeod MJ, Rodger RS, et al. Effect of renal-artery stenting on progression of renovascular renal failure. Lancet. 1997;349:1133-1136.
39. Van de Ven PJ, Beutler JJ, Kaatee R, et al. Transluminal vascular stent for ostial atherosclerotic renal artery stenosis. Lancet. 1995;346:672-674.
40. Iannone LA, Underwood PL, Nath A, et al. Effect of primary balloon expandable renal artery stents on long-term patency, renal function, and blood pressure in hypertensive and renal insufficient patients with renal artery stenosis. Cathet Cardiovasc Diagn. 1996;37:243-250.
41. Dorros G, Prince C, Mathiak L. Stenting of renal artery stenosis achieves better relief of the obstructive lesion than balloon angioplasty. Cathet Cardiovasc Diagn. 1993;29:191-198.
42. Dorros G, Jaff M, Mathiak L, et al. Multicenter Palmaz stent renal artery stenosis revascularization registry report: four-year follow-up of 1058 successful patients. Catheter Cardiovasc Interv. 2002;55:182-188.
43. Fiala LA, Jackson MR, Gillespie DL, et al. Primary stenting of atherosclerotic renal artery ostial stenosis. Ann Vasc Surg. 1998;12:128-133.
44. Plouin PF, Chatellier G, Darne B, et al. Blood pressure outcome of angioplasty in atherosclerotic renal artery stenosis: a randomized trial. Essai Multicentrique Medicaments vs Angioplastie (EMMA) Study Group. Hypertension. 1998;31:823-829.
45. Van de Ven PJ, Kaatee R, Beutler JJ, et al. Arterial stenting and balloon angioplasty in ostial atherosclerotic renovascular disease: a randomised trial. Lancet. 1999;353:282-286.
46. White CJ, Ramee SR, Collins TJ, et al. Renal artery stent placement: utility in lesions difficult to treat with balloon angioplasty. J Am Coll Cardiol. 1999;30:1445-1450.
47. Radermacher J, Chavan A, Bleck J, et al. Use of Doppler ultrasonography to predict the outcome of therapy for renal-artery stenosis. N Engl J Med. 2001;344:410-417.
48. Dorros G, Jaff M, Mathiak L, et al. Four-year follow-up of Palmaz-Schatz stent revascularization as treatment for atherosclerotic renal artery stenosis. Circulation. 1998;98:642-647.
49. Shannon HM, Gillespie IN, Moss JG. Salvage of the solitary kidney by insertion of a renal artery stent. AJR Am J Roentgenol. 1998;171:217-222.
50. Paulsen D, Klow NE, Rogstad B, et al. Preservation of renal function by percutaneous transluminal angioplasty in ischaemic renal disease. Nephrol Dial Transplant. 1999;14:1454-1461.
51. Isles CG, Robertson S, Hill D. Management of renovascular disease: a review of renal artery stenting in ten studies. QJM. 1999;92:159-167.
52. Watson PS, Hadjipetrou P, Cox SV, et al. Effect of renal artery stenting on renal function and size in patients with atherosclerotic renovascular disease. Circulation. 2000;102:1671-1677.
53. Beutler JJ, Van Ampting JM, Van De Ven PJ, et al. Long-term effects of arterial stenting on kidney function for patients with ostial atherosclerotic renal artery stenosis and renal insufficiency. J Am Soc Nephrol. 2001;12:1475-1481.
54. Muray S, Martin M, Amoedo ML, et al. Rapid decline in renal function reflects reversibility and predicts the outcome after angioplasty in renal artery stenosis. Am J Kidney Dis. 2002;39:60-66.
55. Rocha-Singh KJ, Ahuja RK, Sung CH, et al. Long-term renal function preservation after renal artery stenting in patients with progressive ischemic nephropathy. Catheter Cardiovasc Interv. 2002;57:135-141.
56. Zeller T. Endovascular treatment of renal artery stenosis: technical aspects, long-term clinical results, and restenosis-rate. In: Marco J, Serruys P, Biamino G, et al. The Paris Course on Revascularization. 2001:419-450.
57. Zeller T, Müller C, Frank U, et al. Gold coating and restenosis after primary stenting of ostial renal artery stenosis. Catheter Cardiovasc Interv. 2003;60:1-8.
58. Zeller T, Frank U, Späth M. Color duplex ultrasound imaging of renal arteries and detection of hemodynamically relevant renal artery stenoses [in German]. Ultraschall Med. 2001;22: 116-121.
59. Zeller T, Frank U, Müller C, et al. Duplex ultrasound for follow-up examination after stent-angioplasty of ostial renal artery stenoses [in German]. Ultraschall Med. 2002;23:315-319.
60. Levey AS. Clinical practice. Nondiabetic kidney disease. N Engl J Med. 2002;347:1505-1511.
61. Levey AS, Bosch JP, Lewis JB, et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med. 1999;130:461-470.
62. Zeller T, Frank U, Müller C, et al. Technological advances in the design of catheters and devices used in renal artery interventions: impact on complications. J Endovasc Ther. 2003;10:1006-1014.
63. Zeller T, Müller C, Frank U, et al. Survival after stenting of severe atherosclerotic ostial renal artery stenoses. J Endovasc Ther. 2003;10:539-545.
64. Klag MJ, Whelton PK, Randall BL, et al. Blood pressure and end-stage renal disease in men. N Engl J Med. 1996;334:13-18.
65. Hricik DE, Browning PJ, Kopelman R, et al. Captopril-induced functional renal insufficiency in patients with bilateral renal-artery stenoses or renal-artery stenosis in a solitary kidney. N Engl J Med. 1983;308:373-376.
66. Hollenberg NK. Medical therapy of renovascular hypertension: efficacy and safety of Captopril in 269 patients. Cardiovasc Rev Rep. 1983;4:852-876.
67. Toto RD, Mitchell HC, Lee HC, et al. Reversible renal insufficiency due to angiotensin converting enzyme inhibitors in hypertensive nephrosclerosis. Ann Intern Med. 1991;115:513-519.
68. Hansen KJ, Lundberg AH, Benjamin ME, et al. Is renal revascularization in diabetic patients worthwhile? J Vasc Surg. 1996;24:383-393.
69. Mustert BR, Williams DM, Prince MR. In vitro model of arterial stenosis: correlation of MR signal dephasing and trans-stenotic pressure gradients. Magn Reson Imaging. 1998;16:301-310.
70. Rundback JH, Sacks D, Kent KC, et al. Guidelines for the reporting of renal artery revascularization in clinical trials. Circulation. 2002;106:1572-1585.